Key result
Double heterozygous and homozygous carriers of factor V Leiden and prothrombin G20210A mutations were investigated for cardiovascular disease risk, though the abstract lacks specific results.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Roach et al. (2011) studied this question. Double heterozygous and homozygous carriers of factor V Leiden and prothrombin G20210A mutations were investigated for cardiovascular disease risk, though the abstract lacks specific results.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: